Central serous chorioretinopathy

Acta Ophthalmologica - Tập 86 Số 2 - Trang 126-145 - 2008
Maria Wang1, Inger Christine Munch1, Pascal W. Hasler1, Christian Prünte2, Michael Larsen1,3
1Department of Ophthalmology, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark
2Department of Ophthalmology, Medical University of Vienna, Vienna, Austria.
3Kennedy Center, National Eye Clinic, Copenhagen, Denmark

Tóm tắt

Abstract.Central serous chorioretinopathy (CSC) is a disease of the retina characterized by serous detachment of the neurosensory retina secondary to one or more focal lesions of the retinal pigment epithelium (RPE). CSC occurs most frequently in mid‐life and more often in men than in women. Major symptoms are blurred vision, usually in one eye only and perceived typically by the patient as a dark spot in the centre of the visual field with associated micropsia and metamorphopsia. Normal vision often recurs spontaneously within a few months. The condition can be precipitated by psychosocial stress and hypercortisolism. Ophthalmoscopic signs of CSC range from mono‐ or paucifocal RPE lesions with prominent elevation of the neurosensory retina by clear fluid – typical of cases of recent onset – to shallow detachments overlying large patches of irregularly depigmented RPE. The spectrum of lesions includes RPE detachments. Granular or fibrinous material may accumulate in the subretinal cavity. Serous detachment often resolves spontaneously. From first contact, counselling about the potential relation to stress and glucocorticoid medication is warranted. After 3 months without resolution of acute CSC or in chronic CSC, treatment should be considered. Resolution of detachment can usually be achieved in acute CSC by focal photocoagulation of leaking RPE lesions or, in chronic CSC, by photodynamic therapy. The effect of therapy on long‐term visual outcome is insufficiently documented. Reattachment within 4 months of onset is considered a relevant therapeutic target because prolonged detachment is associated with photoreceptor atrophy. This suggests that the value of treatment depends upon proper selection of cases that will not resolve without therapy. Chronic CSC may be difficult to differentiate from occult choroidal neovascularization secondary to CSC. Patients with chronic CSC who receive glucocorticoid treatment for systemic disease can often be managed without having to discontinue this medication.

Từ khóa


Tài liệu tham khảo

10.1016/S0181-5512(04)96281-X

10.1002/ajh.2830410202

10.1055/s-2008-1045583

10.1159/000027522

Bandello F, 2001, ICG et décompensation de l'épithélium pigmenté rétinien (CRSC et épithéliopathies), J Fr Ophtalmol, 24, 448

Bartos D, 1998, Zmeny psychovizuálnich funkci po centrálni serózni chorioretinopatii, Cesk Slov Oftalmol, 54, 166

10.1034/j.1600-0420.2000.078006632.x

10.1007/s004170050123

10.1055/s-2008-1050155

Bonamour G, 1977, Topographische studien über angiographisch beobachtete Läsionen bei Retinitis centralis, Klin Monatsbl Augenheilkd, 171, 862

10.1016/S0039-6257(02)00338-7

10.1136/bjo.78.5.420-b

10.1001/archopht.1993.01090090081024

Brancato R, 1991, Retinopathie séreuse centrale (formes atypiques), Bull Soc Belge Ophtalmol, 240, 119

10.1034/j.1600-0420.2001.079004417.x

Burns SA, 1987, A psychophysical technique for measuring cone photopigment bleaching, Invest Ophthalmol Vis Sci, 28, 711

10.1016/S0161-6420(97)30262-0

Canakis C, 2004, Ocular photodynamic therapy in choroidal neovascularization complicating idiopathic central serous chorioretinopathy, Ophthalmic Surg Lasers Imaging, 35, 168, 10.3928/1542-8877-20040301-17

10.1016/S0002-9394(03)00397-0

10.1097/00006982-200312000-00002

10.1016/S0161-6420(02)01117-X

10.1007/BF00169099

Chaine G, 2001, Choriorétinite séreuse centrale et corticothérapie systémique, J Fr Ophtalmol, 24, 139

10.1136/bjo.87.12.1453

10.1016/S0002-9394(03)00462-8

10.1016/S0161-6420(87)33316-0

Chrapek O, 2002, Lécba centralni sérozni chorioretinopatie betablokátory, Cesk Slov Oftalmol, 58, 382

10.1038/eye.1987.18

10.1016/0002-9394(74)90667-9

Cohen D, 1983, Epitheliopathie rétinienne diffuse et choriorétinopathie séreuse centrale, J Fr Ophtalmol, 6, 339

10.1007/s003470070059

Constantinides G, 2000, Relation entre le décollement séreux de l'épithélium pigmentaire et le point de fuite dans la retinopathie séreuse centrale, J Fr Ophtalmol, 23, 649

10.1076/ceyr.25.5.287.13496

10.1177/112067210601600213

10.1016/S0161-6420(96)30385-0

Desai UR, 2003, Central serous chorioretinopathy in African Americans, J Natl Med Assoc, 95, 553

Dickhoff KV, 1989, Les modifications de la l'épithélium pigmentaire rétinien en rapport avec la rétinopathie séreuse centrale, J Fr Ophtalmol, 12, 877

10.1007/s003470170027

10.1097/00006982-200512000-00006

10.1136/bjo.77.9.607

10.1111/j.1755-3768.1968.tb00935.x

10.1001/archopht.122.1.37

Fabianova J, 1998, Centrálna serózna chorioretinopatia liecba betablokátormi, Cesk Slov Oftalmol, 54, 401

10.1055/s-2008-1055248

10.1111/j.1755-3768.1977.tb06129.x

10.1016/S0002-9394(00)00928-4

10.1016/j.ophtha.2006.01.031

10.1136/bjo.72.11.829

10.1001/archopht.1984.01040031049021

10.1111/j.1600-0420.2005.00442.x

10.1007/BF02172748

10.1055/s-2008-1054851

Fukunaga K, 1969, Central chorioretinopathy with disharmony of the autonomous nerve system, Nippon Ganka Gakkai Zasshi, 73, 1468

10.1007/s003470050310

10.1136/bjo.81.11.962

10.1007/BF00144736

Gass JD, 1967, Pathogenesis of disciform detachment of the neuroepithelium, Am J Ophthalmol, 63, 1

Gass JD, 1977, Photocoagulation treatment of idiopathic central serous choroidopathy, Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol, 83, 456

10.1001/archopht.1991.01080050091036

10.1097/00006982-200504000-00009

10.1016/S0161-6420(95)30960-8

10.1136/bjo.68.11.815

10.1097/00006982-199707000-00002

Gismero MS, 2003, Epiteliopatia en reguero, Arch Soc Esp Oftalmol, 78, 35

10.1097/00006324-199302000-00006

10.1034/j.1600-0420.2000.078002232.x

10.4321/S0365-66912004001000007

Gomolin JE, 1989, Choroidal neovascularization and central serous chorioretinopathy, Can J Ophthalmol, 24, 20

Gonzalez C, 1992, Décollements séreux retiniens, J Fr Ophtalmol, 15, 529

Green RP, 1988, Central serous chorioretinopathy in US Air Force aviators: a review, Aviat Space Environ Med, 59, 1170

10.1159/000307511

10.1007/BF01203689

10.1001/archopht.1994.01090200063023

10.1016/S0161-6420(97)30082-7

10.1016/j.ophtha.2003.09.024

10.1016/S0161-6420(02)01975-9

10.1001/archopht.1985.01050030090029

10.1097/00006982-200110000-00030

10.1159/000309396

10.1007/BF00225936

10.1016/S0002-9394(14)73760-2

Heinrich MR, 1974, Retinopathie séreuse centrale et alpha‐freinateurs, Bull Soc Ophtalmol Fr, 74, 681

10.1007/s004170050174

10.1136/bjo.82.9.1007

10.1111/j.1442-9071.2006.01171.x

10.1136/bjo.77.6.349

Iida T, 1996, Choroidal vascular lesions in serous retinal detachment viewed with indocyanine green angiography, Nippon Ganka Gakkai Zasshi, 100, 817

10.1016/S0002-9394(99)00272-X

10.1001/archopht.120.1.37

10.1097/00006982-200302000-00001

Iwami S, 1995, A new method to elicit pathological entoptic phenomenon from the retina–stenopeic flicker test, Nippon Ganka Gakkai Zasshi, 99, 595

Kanagawa M, 1970, Xenon light‐exposure as a treatment of central serous retinopathy, Nippon Ganka Kiyo, 21, 451

Kanyange ML, 2002, Long‐term follow‐up of central serous chorioretinopathy (CSCR), Bull Soc Belge Ophtalmol, 39

10.1007/s00417-006-0342-2

10.1001/archopht.1974.03900060257001

10.1016/0002-9394(56)90653-5

10.1136/bjo.2006.090282

Larsen M, 2004, Subretinal deposits in central serous chorioretinopathy increase with duration of symptoms, Invest Ophthalmol Vis Sci, 45, E

10.1001/archopht.117.2.184

10.1016/S0896-6273(02)00912-1

10.1016/0002-9394(86)90767-1

Mauget‐Faysse M, 2002, Rôle de l'Helicobacter pylori dans la choriorétinopathie séreuse centrale et l'épithéliiopathie rétinienne diffuse, J Fr Ophtalmol, 25, 1021

10.1023/A:1005880129005

10.1007/s00417-006-0277-7

10.1016/0002-9394(88)90583-1

Mori T, 1990, Dark adaptation in locally detached retina, Invest Ophthalmol Vis Sci, 31, 1259

10.1111/j.1755-3768.1980.tb08316.x

10.1001/archopht.1984.01040030359038

Newman DG, 2002, Central serous retinopathy with permanent visual deficit in a commercial air transport pilot: a case report, Aviat Space Environ Med, 73, 1122

10.1016/j.ophtha.2005.06.026

10.1007/BF00220710

10.1097/00006982-200202000-00005

10.1016/0168-5597(84)90023-6

10.1177/112067219800800110

10.1016/S0161-6420(01)00951-4

Peyman GA, 1972, Peroxidase diffusion in the normal and laser‐coagulated primate retina, Invest Ophthalmol, 11, 35

10.1016/j.ajo.2004.08.037

10.1097/00006982-199414030-00008

10.1136/bjo.79.10.922

10.1007/BF00133176

10.1016/S0002-9394(14)70531-8

10.1016/S0161-6420(96)30730-6

10.1097/00055735-200012000-00009

10.1016/S0161-6420(86)33652-2

10.1016/0002-9394(83)90265-9

10.1016/S0002-9394(02)01428-9

Sadun AA, 1990, Distinguishing between clinical impairments due to optic nerve or macular disease, Metab Pediatr Syst Ophthalmol, 13, 79

10.1007/s10384-005-0244-6

10.1055/s-2002-30660

10.1016/S0161-6420(92)32010-X

10.1016/S0161-6420(95)30908-6

Schatz H, 1977, Subretinal neovascularization following argon laser photocoagulation treatment for central serous chorioretinopathy: complication or misdiagnosis?, Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol, 83, 893

10.1007/s003470170012

10.1016/0002-9394(73)91014-3

Shanmugam MP, 2000, Retinal pigment epithelial tears associated with idiopathic central serous chorioretinopathy, Indian J Ophthalmol, 48, 315

10.1016/j.ophtha.2004.03.025

Shiroyama N, 1990, Analysis of focal macular ERG in idiopathic central serous chorioretinopathy, Nippon Ganka Gakkai Zasshi, 94, 1048

10.1038/sj.eye.6702449

10.1080/10641950500543848

Song E, 1997, Central serous chorioretinopathy induced by corticosteroids, Nippon Ganka Gakkai Zasshi, 101, 257

10.1055/s-2003-812610

10.1016/S0161-6420(96)30386-2

10.1007/BF02334172

10.1007/s00347-006-1396-6

10.1016/S0161-6420(02)01563-4

10.1007/BF02829525

10.1001/archopht.1993.01090030078043

10.2177/jsci.24.125

10.1001/archopht.121.7.975

10.1016/S0002-9394(99)00075-6

Toonen F, 1995, Microperimetry in patients with central serous retinopathy, Ger J Ophthalmol, 4, 311

10.1097/00006982-199901000-00003

10.1016/S0161-6420(02)01065-5

10.1055/s-2006-926567

10.1136/bjo.2005.073056

10.1007/s00417-006-0253-2

Verma SK, 1990, Macular dazzling test in central serous retinopathy using electronic flash, Indian J Ophthalmol, 38, 14

10.1186/1471-2415-4-15

10.1046/j.1440-1606.1999.00158.x

10.1111/j.1600-0420.2005.00582.x

10.1016/S0002-9394(02)01438-1

10.1034/j.1600-0420.1999.770408.x

Watzke RC, 1974, Ruby laser photocoagulation therapy of central serous retinopathy. A preliminary report, Mod Probl Ophthalmol, 12, 242

10.1159/000050855

Werry H, 1978, Investigation in patients with central serous retinopathy with the MMPI Saarbrucken, Klin Monatsbl Augenheilkd, 172, 363

10.1007/978-3-642-47089-9_112

Williams CM, 1976, Visual acuity and colour vision tests – a preliminary report, Br J Physiol Opt, 31, 29

10.1038/sj.eye.6700637

10.1159/000310315

Yannuzzi LA, 1986, Type A behavior and central serous chorioretinopathy, Trans Am Ophthalmol Soc, 84, 799

10.1097/00006982-198700720-00009

10.1016/S0161-6420(99)00173-6

10.1016/S0161-6420(84)34117-3

10.1097/00006982-200306000-00002

10.1177/112067219200200301

10.1001/archopht.1996.01100130681007

Yoshioka H, 1991, The etiology of central serous chorioretinopathy, Nippon Ganka Gakkai Zasshi, 95, 1181

Yoshioka H, 1982, Experimental central serous chorioretinopathy. III: ultrastructural findings, Jpn J Ophthalmol, 26, 397

10.1159/000309239

Thông tin
Thông tin xuất bản

Acta Ophthalmologica

Tập 86 Số 2

126-145

Thông tin tác giả